Beating back the diseases of aging has become something of a pet project for many of Silicon Valley’s tech titans. Earlier this year, Altos Labs, a partial cellular reprogramming company, drew billions of dollars of investment, including from Jeff Bezos and Yuri Milner.
This content was originally published here.